*Department of Ophthalmology, Cincinnati Eye Institute, University of Cincinnati, Cincinnati, OH;
†Virginia Eye Consultants, Norfolk, VA;
‡Clinica degli Occhi Sarnicola, Grosseto, Italy; and
§Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, OH.
Correspondence: Edward J. Holland, MD, Cincinnati Eye Institute, 580 South Loop Rd, Suite 200, Edgewood, KY 41017 (e-mail: [email protected]).
E. J. Holland has consulted for Alcon Laboratories, Allergan, Bausch & Lomb, Kala Pharmaceuticals, Mati Pharmaceuticals, Omeros, PRN, RPS, Senju Pharmaceuticals, Shire, TearLab, and TearScience. A. Y. Cheung has a grant from Eye Bank Association of America. The remaining authors have no conflicts of interest to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.corneajrnl.com).
